Our proven quant model uses 115 proprietary factors, including AI, to determine ZYBT's potential to beat the market
ZYBT doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
Value
N/A
Growth
N/A
Momentum
N/A
Sentiment
N/A
Safety
N/A
Financials
N/A
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ZYBT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ZYBT was unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ZYBT is poor value based on its earnings relative to its share price (44.85x), compared to the US market average (31x)
What is Zhengye Biotechnology Holding's quote symbol?
(NASDAQ: ZYBT) Zhengye Biotechnology Holding trades on the NASDAQ under the ticker symbol ZYBT. Zhengye Biotechnology Holding stock quotes can also be displayed as NASDAQ: ZYBT.
What is the 52 week high and low for Zhengye Biotechnology Holding (NASDAQ: ZYBT)?
(NASDAQ: ZYBT) Zhengye Biotechnology Holding's 52-week high was $6.10, and its 52-week low was $3.70. It is currently -28.69% from its 52-week high and 17.57% from its 52-week low.
How much is Zhengye Biotechnology Holding's stock price per share?
(NASDAQ: ZYBT) Zhengye Biotechnology Holding stock price per share is $4.35 today (as of Feb 10, 2025).
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.